文献速递外周动脉疾病

WIfI分期与衰弱、残疾、生活质量及一年结局在慢性肢体威胁性缺血患者中的关系:单中心前瞻性队列研究

Relationship of the Wound, Ischemia, and Foot Infection Stage with Frailty, Disability, Quality of Life, and One-Year Outcomes in All-Comers with Chronic Limb-Threatening Ischemia: Single-Center Prospective Cohort Study.
PubMed 文献 · Ann Vasc Surg · 2025-11-19

单中心前瞻性队列研究纳入363例慢性肢体威胁性缺血(CLTI)患者,发现WIfI分期越高,衰弱患病率与严重程度及残疾程度越高(P=0.002;P<0.001),但各分期生活质量评分相似。1年大截肢发生率从WIfI 1期的2%(95%CI 0%-11%)升至4期的20%(95%CI 13%-30%),WIfI分期与1年大截肢独立相关(SHR 1.99;95%CI 1.33-2.97;P=0.001)。

要点

  • WIfI分期越高,CLTI患者衰弱和残疾程度越重,但生活质量评分无差异。
  • 1年大截肢率随WIfI分期递增:1期2%、2期7%、3期8%、4期20%。
  • WIfI分期是1年大截肢的独立危险因素(SHR 1.99,95%CI 1.33-2.97)。

核心结论

  • WIfI临床分期与CLTI患者1年大截肢强烈相关。
  • WIfI分期与生活质量无关,可能未反映患者症状的全部严重程度。

研究设计与样本

  • 单中心前瞻性队列研究(NCT04027244),纳入2019年5月至2022年3月就诊的CLTI患者363例。
  • 基线评估衰弱(临床衰弱量表)、残疾(Barthel指数)和生活质量(血管生活质量问卷;EQ-5D-5L)。
  • 采用Fine-Gray竞争风险分析(死亡为竞争风险)探讨WIfI分期与1年大截肢的关联。

主要发现

  • WIfI分期增高与衰弱患病率及严重程度增加相关(P=0.002)。
  • WIfI分期增高与残疾程度加重相关(P<0.001)。
  • 各WIfI分期生活质量评分相似。
  • 1年大截肢发生率:WIfI 1期2%(95%CI 0%-11%),2期7%(95%CI 4%-14%),3期8%(95%CI 4%-15%),4期20%(95%CI 13%-30%)。
  • WIfI分期与1年大截肢独立相关(SHR 1.99;95%CI 1.33-2.97;P=0.001)。

临床怎么用

  • WIfI分期可用于CLTI患者1年大截肢风险分层,分期越高截肢风险越高。
  • 对WIfI高分期患者应同时评估衰弱和残疾,以全面把握病情。
  • WIfI分期不能替代生活质量评估,需单独关注患者症状负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The wound, ischemia and foot infection (WIfI) classification system has been widely adopted in chronic limb-threatening ischemia (CLTI) management. Primary aim was to prospectively investigate the association of WIfI stage with 1-year major amputation. Secondary aims included investigating associations of WIfI stage with baseline frailty, disability, and quality of life (QoL). METHODS: Single-center prospective cohort study (NCT04027244). CLTI patients presenting between May 2019 and March 2022 were eligible. Frailty (clinical frailty scale), disability (Barthel index), and QoL (vascular QoL questionnaire; EQ-5D-5L) assessments were performed at baseline. Major amputation incidence for each WIfI stage was presented as percentages with 95% confidence intervals (CIs). Association of WIfI stage with 1-year major amputation was investigated using Fine-Gray competing risk analysis (death as competing risk), reported as subdistribution hazard ratios (SHRs) with 95% CI. RESULTS: A total of 363 patients were included. Increasing WIfI stage was associated with increasing frailty prevalence and frailty severity (P = 0.002), and greater disability (P < 0.001). QoL scores were similar for each WIfI stage. Major amputation incidence at 1-year was 2% (95% CI, 0%-11%) for WIfI stage 1, 7% (95% CI, 4%-14%) stage 2, 8% (95% CI, 4%-15%) stage 3, and 20% (95% CI, 13%-30%) for stage 4. Increasing WIfI stage was independently associated with 1-year major amputation (SHR, 1.99; 95% CI, 1.33-2.97; P = 0.001). CONCLUSION: WIfI clinical stage is strongly associated with major amputation at 1-year in patients with CLTI. Given its lack of association with QoL, WIfI stages may not reflect the full severity of symptoms experienced by patients.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Houghton JSM, Black I, Meffen A, et al. Relationship of the Wound, Ischemia, and Foot Infection Stage with Frailty, Disability, Quality of Life, and One-Year Outcomes in All-Comers with Chronic Limb-Threatening Ischemia: Single-Center Prospective Cohort Study. Ann Vasc Surg. 2025. PMID: 41271091. doi:10.1016/j.avsg.2025.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。